Ranitidine Hydrochloride 25mg/mL, 30mL Injection

Ranitidine injection is an H2-receptor blocker for acid-related disease when parenteral treatment is required. Its role includes selected ulcer and acid-hypersecretion regimens.
A healthcare professional gives ranitidine by intramuscular injection or by diluted, slow intravenous administration. Rapid intravenous injection can cause cardiovascular reactions. Kidney function affects the treatment amount and the interval between injections.
Blocking histamine H2 receptors on stomach parietal cells reduces acid secretion, including secretion between meals and overnight.
Headache, constipation, diarrhoea and dizziness may occur; injection can cause local discomfort or, rarely, heart-rate changes.
Kidney impairment may require a different schedule. Persistent swallowing difficulty, unexplained weight loss or gastrointestinal bleeding needs investigation rather than continued acid suppression alone.
Reduces acid exposure so acid-related symptoms can improve and damaged mucosa can heal.
Rapid intravenous administration can cause a slow or abnormal heartbeat, dizziness or a fall in blood pressure. Dilution and controlled administration reduce avoidable injection-related risk.
No. An H. pylori ulcer needs an appropriate antibiotic eradication regimen.
Yes. Ranitidine is cleared through the kidneys, so reduced kidney function can increase exposure.
Black tarry stools, vomiting blood or fainting can indicate bleeding and need prompt care.
Persistent or recurrent symptoms need assessment for the underlying cause and treatment suitability.
No. Route, concentration and clinical circumstances determine the injectable regimen.
It reduces new acid production rather than directly neutralising acid already present.
Yes. Medicines needing an acidic stomach for absorption may be affected; include antifungal and HIV treatments in the medication review.
H2 receptor: a histamine receptor that stimulates stomach-acid secretion. Reflux: backward flow of stomach contents into the oesophagus. Hypersecretion: excessive acid production. Renal clearance: removal of a medicine through the kidneys., AR: Ranitidine Hydrochloride /mL, حقن, FR: Ranitidine Hydrochloride /mL, PT: Ranitidine Hydrochloride /mL, injeção, ES: Ranitidine Hydrochloride /mL, inyección, RU: Ranitidine Hydrochloride /mL, инъекция, ID: Ranitidine Hydrochloride /mL, injeksi, VI: Ranitidine Hydrochloride /mL, thuốc tiêm, MS: Ranitidine Hydrochloride /mL, suntikan, TL: Ranitidine Hydrochloride /mL, iniksyon, ZH-SG: Ranitidine Hydrochloride /mL, 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Ranitidine Hydrochloride 25mg/mL, 30mL Injection under Digestive Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Ranitidine Hydrochloride 25mg/mL, 30mL Injection